Erste Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $419K | Hold |
13,100
| – | – | ﹤0.01% | 656 |
|
|
2025
Q1 | $435K | Hold |
13,100
| – | – | 0.01% | 438 |
|
|
2024
Q4 | $448K | Hold |
13,100
| – | – | 0.01% | 446 |
|
|
2024
Q3 | $513K | Hold |
13,100
| – | – | 0.01% | 435 |
|
|
2024
Q2 | $412K | Hold |
13,100
| – | – | 0.01% | 431 |
|
|
2024
Q1 | $439K | Hold |
13,100
| – | – | 0.01% | 436 |
|
|
2023
Q4 | $437K | Hold |
13,100
| – | – | 0.01% | 438 |
|
|
2023
Q3 | $450K | Hold |
13,100
| – | – | 0.01% | 417 |
|
|
2023
Q2 | $463K | Hold |
13,100
| – | – | 0.01% | 420 |
|
|
2023
Q1 | $428K | Hold |
13,100
| – | – | 0.01% | 437 |
|
|
2022
Q4 | $723K | Hold |
13,100
| – | – | 0.02% | 393 |
|
|
2022
Q3 | $572K | Hold |
13,100
| – | – | 0.01% | 404 |
|
|
2022
Q2 | $661K | Hold |
13,100
| – | – | 0.01% | 397 |
|
|
2022
Q1 | $653K | Buy |
+13,100
| New | +$653K | 0.01% | 410 |
|